Physician
Mouton, Mark
Mouton, Mark was paid $894K by Medicaid between Jan 2018 and Nov 2024, across 41 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 53% of everything it billed.
33Billing provider infoMOUTON, MARK
BAKER, LA 70714
BAKER, LA 70714
33aNPI1164613758assigned 08/07/2007
33bProvider typeInternal Medicine Physician
28Total paid$894K
24GClaims32,037
24DCodes billed41
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Internal Medicine Physician providers in Louisiana
Rank by total paid#25 of 290
Median peer was paid$27K
This provider vs. median33×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,235 | $82K | |
| 2019 | 2,307 | $98K | |
| 2020 | 2,796 | $105K | |
| 2021 | 3,492 | $98K | |
| 2022 | 5,340 | $135K | |
| 2023 | 8,910 | $198K | |
| 2024incomplete | 6,957 | $178K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 53% | 10,357 | 8,529 | $474K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 35% | 10,246 | 7,995 | $314K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 2.6% | 751 | 561 | $23K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.4% | 466 | 395 | $22K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.1% | 5,034 | 2,949 | $18K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.5% | 239 | 209 | $13K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 1.1% | 227 | 26 | $10K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 77 | 65 | $5K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 77 | 68 | $4K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 38 | 38 | $2K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 248 | 166 | $2K |
| 90756 | <1% | 88 | 66 | $1K |
29 more codes
| 93000 | <1% | 112 | $1K | |
| 90686 | <1% | 59 | $1K | |
| 81002 | <1% | 617 | $660.40 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 144 | $656.50 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 910 | $563.75 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 298 | $399.54 |
| 20610 | <1% | 24 | $396.02 | |
| 90688 | <1% | 22 | $295.44 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 30 | $217.28 |
| 90661 | <1% | 14 | $147.40 | |
| J1071 | Injection, testosterone cypionate, 1 mg | <1% | 66 | $126.03 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 885 | $71.16 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 21 | $37.93 |
| 36415 | Collection of venous blood by venipuncture | <1% | 15 | $27.95 |
| 0513F | <1% | 64 | $10.00 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 327 | $6.70 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 283 | $1.53 |
| 3074F | 0% | 32 | $0.00 | |
| 4010F | 0% | 18 | $0.00 | |
| 3066F | 0% | 13 | $0.00 | |
| 2000F | 0% | 65 | $0.00 | |
| 99000 | 0% | 15 | $0.00 | |
| 1101F | 0% | 17 | $0.00 | |
| 1090F | 0% | 17 | $0.00 | |
| 3078F | 0% | 59 | $0.00 | |
| 1026F | 0% | 13 | $0.00 | |
| 0518F | 0% | 18 | $0.00 | |
| 4145F | 0% | 14 | $0.00 | |
| 3288F | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.